United Therapeutics Corp
XMUN:UTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
United Therapeutics Corp
XMUN:UTH
|
US |
|
1
|
11 Bit Studios SA
DUS:11C
|
PL |
|
DiaMedica Therapeutics Inc
NASDAQ:DMAC
|
US |
|
B
|
Bombardier Inc
F:BBDB
|
CA |
|
3
|
3M Co
XHAM:MMM
|
US |
|
J
|
J Sainsbury PLC
XMUN:SUY1
|
UK |
|
S
|
Sealed Air Corp
F:SDA
|
US |
|
Oroco Resource Corp
XTSX:OCO
|
CA |
|
C
|
Cronos Group Inc
NASDAQ:CRON
|
CA |
|
D
|
Danske Bank A/S
DUS:DSN
|
DK |
|
Limbach Holdings Inc
F:J4B
|
US |
|
Moncler SpA
F:MOV
|
IT |
|
Namura Shipbuilding Co Ltd
OTC:NMRSF
|
JP |
|
W
|
WW International Inc
F:WW6
|
US |
|
Digital Turbine Inc
NASDAQ:APPS
|
US |
|
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
CA |
|
E
|
Elica SpA
F:7L4
|
IT |
|
D
|
Deep Yellow Ltd
XMUN:JMI
|
AU |
|
F
|
FutureFuel Corp
SWB:3FF
|
US |
|
H
|
Hacksaw AB
STO:HACK
|
SE |
|
B
|
BP PLC
F:BPE5
|
UK |
|
Daiei Kankyo Co Ltd
OTC:DKCLF
|
JP |
Bankruptcy Probability
United Therapeutics Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
United Therapeutics Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
22.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
458.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
United Therapeutics Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, United Therapeutics Corp has no debt.
You can find a full breakdown on its Balance Sheet.
